Clonal Types of Oral Yeasts in Relation of Age, Health, and Geography by Hannula, Johanna
Institute of Dentistry, Department of Periodontology, University of Helsinki,
Finland
CLONAL TYPES OF ORAL YEASTS IN RELATION
TO AGE, HEALTH, AND GEOGRAPHY
Johanna Hannula
Academic Dissertation
To be presented, with the permission of the Faculty of Medicine of the
University of Helsinki, for public discussion in the main auditorium of the
Institute of Dentistry, Mannerheimintie 172, on 16 June, 2000, at 12 noon.
Helsinki 2000
2SUPERVISORS:
Docent Sirkka Asikainen, DDS, PhD
Institute of Dentistry
University of Helsinki
Helsinki, Finland
Docent Maria Saarela, PhD
VTT Biotechnology
VTT, Espoo, Finland
REVIEWERS:
Docent Malcolm D. Richardson, PhD, FIBiol, FRCPath
Department of Bacteriology and Immunology
Haartman Institute
University of Helsinki
Helsinki, Finland
Docent Marianne Lenander-Lumikari, DDS, PhD
Institute of Dentistry
University of Turku
Turku, Finland
OPPONENT:
Professor Casey Chen, DDS, PhD
Department of Periodontology
School of Dentistry
University of Southern California
Los Angeles, California, USA
ISBN 952-91-2216-0 (nid.)
ISBN 952-91-2270-5 (PDF version)
Helsingin yliopiston verkkojulkaisut, Helsinki 2000
3                              To Jussi
4CONTENTS
ABBREVIATIONS.................................................................................................................... 6
LIST OF ORIGINAL PUBLICATIONS ................................................................................... 7
INTRODUCTION...................................................................................................................... 8
REVIEW OF THE LITERATURE............................................................................................ 9
THE ORAL CAVITY AS A HABITAT OF YEASTS......................................................... 9
ORAL YEASTS IN HEALTH AND DISEASE................................................................. 10
CANDIDOSIS..................................................................................................................... 12
ACQUISITION OF ORAL YEASTS ................................................................................. 14
CANDIDA ALBICANS......................................................................................................... 15
Taxonomy.............................................................................................................. 15
Virulence factors ................................................................................................... 15
Characterization of C. albicans isolates ................................................................ 17
Phenotyping ................................................................................................. 17
Biotyping ............................................................................................ 17
Serotyping........................................................................................... 18
Genotyping................................................................................................... 20
AIMS OF THE STUDY........................................................................................................... 22
MATERIAL AND METHODS ............................................................................................... 24
SUBJECTS AND YEAST ISOLATES............................................................................... 24
CULTURE AND IDENTIFICATION OF YEAST SPECIES............................................ 25
PHENOTYPIC CHARACTERIZATION OF THE YEAST ISOLATES .......................... 26
Biotyping ............................................................................................................... 26
Serotyping ............................................................................................................. 26
Virulence factors ................................................................................................... 26
GENOTYPIC CHARACTERIZATION OF THE YEAST ISOLATES ............................ 27
DNA extraction ..................................................................................................... 27
Genotyping ............................................................................................................ 27
STATISTICAL ANALYSES.............................................................................................. 27
RESULTS AND DISCUSSION .............................................................................................. 28
ORAL YEAST SPECIES IN YOUNG CHILDREN.......................................................... 28
Occurrence............................................................................................................. 28
Stability of colonization ........................................................................................ 29
Yeast transmission from the mother...................................................................... 30
5IDENTIFICATION, OCCURRENCE AND CHARACTERISTICS OF C. DUBLINIENSIS
............................................................................................................................................. 32
INTERINDIVIDUAL HETEROGENEITY OF ORAL YEASTS ..................................... 34
Geographical differences....................................................................................... 34
Yeast species................................................................................................ 34
C. albicans biotypes and serotypes.............................................................. 35
C. albicans genotypes .................................................................................. 35
C. albicans isolates in relation to systemic health................................................. 36
Genotypes and virulence factors .................................................................. 36
INTRAINDIVIDUAL HETEROGENEITY OF ORAL YEASTS..................................... 37
Yeast species ......................................................................................................... 37
C. albicans serotypes and genotypes..................................................................... 38
C. dubliniensis genotypes...................................................................................... 39
SUBGINGIVAL C. ALBICANS AND OCCURRENCE OF PERIODONTAL
PATHOGENS ..................................................................................................................... 39
SUMMARY AND CONCLUSIONS....................................................................................... 41
REFERENCES......................................................................................................................... 44
ACKNOWLEDGMENTS........................................................................................................ 57
6ABBREVIATIONS
AIDS acquired immunodeficiency syndrome
APECED autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy
AP-PCR arbitrarily primed polymerase chain reaction
CCUG Culture Collection, University of Göteborg, Sweden
CFU colony-forming unit
DNA deoxyribonucleic acid
EDTA ethylenediaminetetra-acetic acid
HIV human immunodeficiency virus
NCPF National Collection of Pathogenic Fungi
PCR polymerase chain reaction
RAPD randomly amplified polymorphic DNA
REA restriction endonuclease analysis
REP-PCR repetitive extragenic palindromic-polymerase chain reaction
RFLP restriction fragment length polymorphism
SDA Sabouraud dextrose agar
TSBV tryptic soy serum bacitracin vancomycin
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8INTRODUCTION
Yeasts are opportunistic pathogens and common members of the normal oral flora in
humans. However, the source of early yeast infection and time and stability of colonization of
yeast species are poorly understood. Yeasts have attracted growing interest among researchers
due to the increased incidence of severe oral candidosis. The condition mainly results from
the widespread use of antibiotics and rising proportions of aged and immunocompromised
individuals in the population. Candida albicans is the most common yeast species in the
human oral cavity. Immunocompromised individuals are, however, prone to infections by
otherwise rare yeast species, such as Candida dubliniensis, Candida tropicalis, Candida
parapsilosis, Candida krusei, Candida kefyr, Candida glabrata, and Candida guilliermondii.
Among these, C. dubliniensis is a new, recently described species which was originally
described from severe oral candidosis of subjects infected with human immunodeficiency
virus (HIV) and was therefore suspected of increased virulence.
In the oral cavity, yeasts can be found on mucosal surfaces and in saliva but also
occasionally in inflamed periodontal pockets. However, their role in periodontal destruction is
unknown. Subgingival yeasts may be merely innocent bystanders and only reflect
colonization on oral surfaces. In some individuals the subgingival ecosystem may favor yeasts
or enhance growth of certain yeast strains since yeast species or strains may vary in their
ability to coaggregate with subgingival bacteria and to survive in the low oxyxen tension of
the periodontal pocket. Thus, different yeast species or strains may colonize different areas in
the oral cavity. Today, limited data exist on the interindividual and intraindividual
heterogeneity of oral yeast species or strains, especially in systemically healthy subjects.
Previous studies mainly included either immunocompromised individuals or only a single
yeast isolate within a subject. Analyses of several strains within subjects are important, since
even among strains of the same species virulence characteristics may vary.
In the present study, phenotypic and genotypic techniques were used to determine
clonal diversity of oral yeast isolates from children and adults. The timing, stability, and
infection route of oral yeast colonization in healthy young children up to the age of two years
were addressed. To identify strains with increased pathogenic potential, clonal distribution
and heterogeneity of oral C. albicans species was first determined between isolates recovered
from geographically distant locales and systemically healthy subjects and then compared to
those of isolates from subjects especially susceptible to yeast infections. Serotypes and
genotypes of C. albicans isolates from periodontal pockets were related to subgingival
ecology as assessed by the co-existence of various periodontopathogenic bacteria. Finally,
certain virulence attributes were compared within C. albicans species and between C.
albicans and C. dubliniensis species.
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THE ORAL CAVITY AS A HABITAT OF YEASTS
The oral cavity comprises diverse surfaces and microenvironments enabling
colonization of a wide variety of microorganisms. Mucous membranes line the oral surfaces,
which are pierced by teeth and ducts of the salivary glands. The flushing action of saliva
removes non-adherent microorganisms from oral surfaces. Decreased saliva secretion
(Parvinen & Larmas 1981, Meurman & Rantonen 1994, Almståhl et al. 1999) may result in
increased recovery of yeasts, perhaps due to decreased quantities of candidacidal molecules,
including lysozyme (Tobgi et al. 1988), histatins (Jainkittivong et al. 1998), peroxidases
(Lenander-Lumikari 1992), and lactoferrin (Nikawa et al. 1993). On the other hand, saliva
also contains microbial nutrients, such as glucose (Knight & Fletcher 1971), which facilitate
proliferation of yeasts (Samaranayake et al. 1986a), and mucins, which contribute to adhesion
of yeasts to oral surfaces (Hoffman & Haidaris 1993).
Candida species grow best under aerobic conditions but are also able to grow under
elevated concentrations of CO2 in air (Webster & Odds 1986). Reports on the ability of
Candida albicans to grow in anaerobiosis have been equivocal (Kennedy 1981,
Samaranayake et al. 1983, Webster & Odds 1986). Some oral sites with low oxygen tension,
such as buccal folds and periodontal pockets (Eskow & Loesche 1971, Loesche et al. 1983),
may not be favorable for the proliferation of Candida. Anaerobes grow at low oxygen tension
(Loesche et al. 1983), negative oxidation-reduction potential (Kenney & Ash 1969), and basic
pH (Eggert et al. 1991), an environment unfavorable for growth of yeasts.
C. albicans can form on oral surfaces an adherent biofilm together with other oral
microbiota and host glycoproteins (Holmes et al. 1995). Coaggregation of Candida with oral
bacteria is believed to play an important role in the establishment of candidal colonization and
candidosis (Bagg & Silverwood 1986). C. albicans binds to bacteria such as viridans
streptococci (Jenkinson et al. 1990, Holmes et al. 1996), Fusobacterium (Grimaudo & Nesbitt
1997), and Actinomyces species (Grimaudo et al. 1996). Coaggregation of yeast and
streptococci may be enhanced by adsorption of salivary proteins by the streptococci to
provide additional adhesin-receptor interactions (Holmes et al. 1995, O'Sullivan et al. 2000).
The biofilm can persist as a sessile population of yeasts whose eradication would require
removal of the base to which it adheres (Baillie & Douglas 1998).
In healthy individuals the oral recovery of yeasts is about 34% varying from 2% to
71% (Odds 1988b) probably due to the sampling method or site and study population
(Arendorf & Walker 1980, Odds 1988b, Brambilla et al. 1992). The numbers of yeasts
isolated from the oral cavity of healthy carriers are usually low. In hospitalized patients oral
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yeasts are recovered from about 55%, the oral recovery of yeasts varying from 13% to 76%
(Odds 1988b).
"The normal oral flora" and "commensals" are terms used for microbes that are almost
always present in high numbers in the oral cavity of healthy individuals (Liljemark &
Bloomquist 1988, Loesche 1988), meaning that they live in the host, and derive benefit from
the host without causing injury (Liljemark & Bloomquist 1988, Asikainen & Chen 1999).
Persons infected with disease-causing microbes are called carriers because they do not have
symptomatic clinical disease, but can spread an infection to other persons (Salyers & Whitt
1994a). Yeasts can act as opportunistic pathogens, since they, as members of the normal flora,
can cause disease in the compromised host (Liljemark & Bloomquist 1988, Cannon & Chaffin
1999). The persistent presence and multiplication of commensal yeast in the oral cavity is
called colonization (Salyers & Whitt 1994a, Salyers & Whitt 1994b). The term "infection" is
regarded as successful colonization and multiplication by yeasts capable of causing damage to
the host in the oral cavity (Liljemark & Bloomquist 1988, Salyers & Whitt 1994b), and an
infection that produces symptoms is known as disease (Salyers & Whitt 1994a). Infection can
also be regarded as disruption of the host and production of a characteristic group of
symptoms (Liljemark & Bloomquist 1988). For disease to occur, yeasts have to adhere and
invade host tissues by passing through mucosal surfaces and spreading through the body,
penetrating the host's defenses (Salyers & Whitt 1994a, Salyers & Whitt 1994b).
ORAL YEASTS IN HEALTH AND DISEASE
Yeasts are opportunistic pathogens but also regarded as members of the normal oral
flora (Arendorf & Walker 1979, Odds 1988b). The dorsum of the tongue is the primary oral
reservoir for yeasts (Arendorf & Walker 1980), but yeasts can be also recovered from other
oral mucosae, tooth surfaces, and saliva (Arendorf & Walker 1980, Borromeo et al. 1992,
Tillonen et al. 1999). In addition to the healthy oral cavity, yeasts have also been found in oral
cavities showing dental diseases, such as enamel caries (Hodson & Craig 1972, Sziegoleit et
al. 1999), root caries (Lynch & Beighton 1994), and periodontal disease (Slots et al. 1988,
Rams & Slots 1991), but the role of yeasts in the etiology of these diseases remains unknown.
However, yeasts may play a role in persistent apical periodontitis (Waltimo et al. 1997). High
salivary Candida counts are related to increased prevalence of caries (Pienihäkkinen et al.
1987), probably because yeasts thrive in the acidic conditions which the caries lesion offers.
The levels of oral yeasts increase along with the presence of fixed or removable
orthodontic appliances (Addy et al. 1982) and complete or partial dentures (Budtz-Jörgensen
et al. 1975, Berdicevsky et al. 1980, Vandenbussche & Swinne 1984). Studies show that
insufficient oral hygiene care and dentures are significant predisposing factors to oral
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candidosis (Budtz-Jörgensen 1974). The underlying reasons include environmental changes
beneath dentures, such as low pH (Budtz-Jörgensen 1990), which increases the adherence of
Candida to epithelial and acrylic surfaces (Samaranayake et al. 1980, Samaranayake &
MacFarlane 1982). Diets rich in carbohydrates have been suggested to predispose denture
wearers to oral candidosis (Samaranayake 1990a). However, recently it has been shown that
adding a high amount of refined carbohydrates to the diet of healthy subjects did not increase
the number of C. albicans-positive subjects (Weig et al. 1999).
Some studies have suggested that tobacco smoking increases oral Candida carriage
rates (Arendorf & Walker 1980, Kamma et al. 1999, Willis et al. 1999), whereas others have
found no association between smoking and yeast carriage (Bastiaan & Reade 1982, Oliver &
Shillitoe 1984, Liede et al. 1999). Nevertheless, smoking leads to localized epithelial
alterations such as leukoplakic lesions which may enhance colonization of oral Candida
(Rindum et al. 1994).
C. albicans is the most commonly isolated yeast species in the oral cavity both in
health and disease (Odds 1988b). It accounts for about 47% to 75% of the oral yeast isolates,
while other medically important yeast pathogens, Candida tropicalis, Candida parapsilosis,
Candida krusei, Candida kefyr, Candida glabrata, and Candida guilliermondii, each
represent less than 10% of isolates (Odds 1988b). According to recent reports yeast species
other than C. albicans cause increasing number of infections (Hazen 1995), including
arthritis, osteomyelitis, endocarditis, endopthalmitis, meningitis, and fungemia (Fridkin &
Jarvis 1996).
Yeasts, especially C. albicans (Slots et al. 1988, Rams & Slots 1991), are recovered
not only from the oral mucosae, but are also recovered from periodontal pockets in some
patients with adult periodontitis (20%) (Slots et al. 1988, Rams et al. 1990, Slots et al. 1990,
Dahlén & Wikström 1995). It is not known whether subgingival C. albicans or other yeasts
participate in the pathogenesis of destructive periodontal disease, or whether the organism is
merely an innocent bystander in periodontal pockets indicating its colonization or even
candidal disease at other oral sites. Periodontitis is generally regarded as a mixed bacterial
infection (Haffajee & Socransky 1994) for which anaerobic gram-negative bacteria (Slots
1979, Haffajee & Socransky 1994), including Porphyromonas gingivalis and Actinobacillus
actinomycetemcomitans, and additionally Bacteroides forsythus, Prevotella intermedia sensu
lato, and Campylobacter rectus, are the primary etiological agents (Zambon 1996). As stated,
Candida species and anaerobic periodontal pathogens clearly differ in their growth
requirements. Therefore, it can be anticipated that they are not able to thrive for extended
periods of time in the same highly specified ecological niche. However, it is possible that
ecological changes, e.g. those due to antibiotics (Helovuo 1986, Rams et al. 1990) or
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immunocompromising disease or treatment (Slots & Rams 1991) may lead to subgingival
yeast overgrowth and even superinfections.
CANDIDOSIS
Candida infections are called candidosis or candidiasis, terms used in the literature as
synonyms. The International Society for Human and Animal Mycology (1980) has suggested
the term "candidosis", while the Council for International Organizations of Medical Sciences
(1982) recommends "candidiasis". The former term will be used in this thesis.
Several factors, such as virulence of the infecting yeast strains, host resistance, and
various environmental factors, including sugars and antibacterial drugs (Scully et al. 1994),
influence risk for the development of candidosis (Samaranayake 1990b). Despite intense
research, no single particular virulence factor of any yeast species has been found to cause
candidosis (Cutler 1991, Matthews 1994, Odds 1994). Rather, a combination of virulence
mechanisms, such as adhesins, rapid phenotypic switching, hyphal growth, and secretion of
hydrolytic enzymes, seems to be responsible for the development of candidosis, since at
different stages of candidosis different virulence factors are expressed (Cutler 1991).
An association exists between candidosis and diseases leading to suppression in
systemic and local host defenses (Samaranayake 1990a) (Table 1). For instance, in
immunocompromising endocrine disorders, including diabetes mellitus, the frequency of oral
candidosis increases (Dorocka-Bobkowska et al. 1996, Vitkov et al. 1999). In malignant
diseases without therapy the incidence of oral candidosis is greater than in healthy subjects
(Scully et al. 1994). Immunosuppressive and corticosteroid therapy lower the host resistance
to microbial infections and oral candidosis (Odds 1988c), and the use of broad-spectrum
antibiotics suppresses the competing indigenous bacterial flora (Seelig 1966), predisposing
the host to over-growth of Candida and subsequently to the development of candidosis. In
immunocompromised hosts, oral and non-oral candidosis may develop as an endogenous
infection (Powderly et al. 1993, Voss et al. 1994) but also can be due to the replacement of
original commensal strains by a new invader (Schmid et al. 1992, Powderly et al. 1993).
Additionally, altered nutritional status of the host, including iron deficiency (Higgs 1973,
Fletcher et al. 1975) and folate deficiency (Samaranayake & MacFarlane 1981), are
associated with oral candidosis.
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Table 1. Factors, proposed in the literature, predisposing to oral candidosis.
Local factorsa Systemic factors
Mucosal barrier Certain physiological states
        Ill-fitting dental appliances            Infancy
                  Trauma            Old age
                  Changes in oral environmental conditions Endocrine disorders
                  Inadequate home care of oral dental appliances            Diabetes
        Endogenous epithelial changes            Hypothyroidism
                 Atrophy Nutritional deficiencies
                 Hyperplasia            Iron deficiency
                 Dysplasia            Folate deficiency
Saliva            Vitamin B12 deficiency
        Quantitative changes Malignancies
                 Xerostomia             Acute leukemia
                 Hyposalivation             Agranulocytosis
        Qualitative changes Immune defects
                 pH            HIV infection
                 Glucose concentration            Thymic aplasia
Bacteria-yeast coaggregation Pharmacotherapy
High-carbohydrate diet             Broad-spectrum antibiotics
Tobacco smoking             Corticosteroids
            Cytotoxic drugs
a Modified from Samaranayake (1990a), Scully et al. (1994) and Budtz-Jörgensen & Lombardi (1996).
The most frequently used classification to describe various types of oral candidosis is
by Lehner (Lehner 1967). The categories in Lehner's classification include acute
pseudomembranous candidosis, acute atrophic candidosis, chronic atrophic candidosis, and
chronic hyperplastic candidosis. The latter comprises chronic oral candidosis, endocrine
candidosis syndrome, chronic localized mucocutaneous candidosis, and chronic diffuse
candidosis (Lehner 1964).
Acute pseudomembranous candidosis, commonly referred to as oral thrush
(Samaranayake & Yaacob 1990), is characterized by whitish plaques on tongue and oral
mucosal surfaces (Korting 1989, Samaranayake & Holmstrup 1989, Holmstrup & Axéll
1990). After removal of plaque, the erythematous mucosal base is exposed. The acute
atrophic candidosis, also called midline glossitis or median rhomboid glossitis (Samaranayake
& Yaacob 1990), is a possible consequence of the removal of the pseudomembrane
(Holmstrup & Axéll 1990). It typically appears on the midline of the dorsal surface of the
tongue and is often associated with loss of lingual papillae. In chronic atrophic candidosis, or
denture stomatitis (Samaranayake & Yaacob 1990), chronic erythema is usually seen in the
palate underlying the denture (Budtz-Jörgensen & Bertram 1970). Denture stomatitis is
frequently associated with angular cheilitis, or perléche (Korting 1989, Samaranayake &
Yaacob 1990). In chronic hyperplastic candidosis, or Candida leukoplakia (Samaranayake &
Yaacob 1990), the whitish plaques―which vary from barely palpable patches to firmly
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adherent rough plaques on the tongue, palate, or buccal mucosa―are not easily scraped off
(Korting 1989, Samaranayake & Holmstrup 1989).
The antifungal agents used currently in the treatment of oral candidosis are azoles:
clotrimazole, miconazole, ketonazole, itraconazole, and fluconazole, polyenes: nystatin and
amphotericin B, and the disinfectant chlorhexidine gluconate (Budtz-Jörgensen & Lombardi
1996, Cross et al. 2000). The azoles inhibit the cytochrome P-450 enzyme, lanosterol 14α
demethylase, in fungal organisms and block steroid synthesis in the fungal cell membrane.
This interference leads to increased permeability of the cell membrane (White 1997). The
polyenes target ergosterol in the fungal plasma membrane and form pores, leading to
increased membrane permeability (White 1997). Chlorhexidine may mainly inhibit the
adherence of Candida species to oral mucosa and acrylic surfaces (Budtz-Jörgensen &
Lombardi 1996).
ACQUISITION OF ORAL YEASTS
Knowledge of the potential sources of yeasts colonizing the oral cavities of infants is
limited. The mother's vaginal canal has been suggested as one source of oral yeasts in
newborns (Kozinn et al. 1958, Alteras & Aryeli 1980, Baley et al. 1986). Since C. albicans is
the most common yeast species in the vagina (64-72% of yeast isolates) (Sonck 1978,
Goldacre et al. 1981), it is unlikely that infants would commonly acquire other yeast species
besides C. albicans from their mothers during the delivery. Other possible origins of oral
yeasts to the newborn are the hands, skin, mouth, and throat of people taking care of the infant
(Pedersen 1969, Sharp et al. 1992, Weems 1992, Sanchez et al. 1993). Only a few studies
exist, mainly case-reports, on person-to-person transmission of oral yeasts between family
members, such as between husband and wife (Schmid et al. 1990, Mehta et al. 1999), between
siblings (Mehta et al. 1999), and between a parent and child (Mehta et al. 1999). Therefore,
further studies using larger study populations are needed to determine whether the mother or
other care-givers may be major sources of oral yeast infection in early childhood.
C. albicans can be recovered from environmental samples, such as water, soil, and
plants, with human or animal sources probably the origin of the organism (Odds 1988b). C.
albicans survives well on moist surfaces and can be isolated from the toothbrushes of subjects
with oral yeasts (Koch & Koch 1981). It may also survive in eye cosmetics (Wilson et al.
1971) and hand cream (France 1968). An endophthalmitis outbreak in drug addicts was
thought to result from a contaminated diluent used in injections (Shankland & Richardson
1988). In hospitals, Candida species are a frequent finding in air, in foods, and on floors and
other surfaces (Odds 1988b). Therefore, a nosocomial source is possible if hospitalized
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patients acquire oral yeasts (Schmid et al. 1990, Vazquez et al. 1993, Robert et al. 1995). In
immunocompromised HIV-infected couples, both partners have harbored oral yeasts
(Sangeorzan et al. 1994) and among 60% (3/5) of these couples the same C. albicans strain
was recovered from both partners (Sangeorzan et al. 1994). In contrast, systemically healthy
partners of subjects with HIV infection did not usually harbor oral yeasts (Sangeorzan et al.
1994).
CANDIDA ALBICANS
Taxonomy
C. albicans belongs to the kingdom Fungi, the division Eumycota (true fungi), the
biologically diverse class Deuteromycetes or Fungi Imperfecti and to the genus Candida
(Carlile & Watkinson 1996). The genus Candida comprises more than 150 species (Odds
1987) which are characteristically white asporogenous yeasts able to form pseudohyphae.
Species within the genus Candida are characterized primarily by colonial morphology, carbon
assimilation, and fermentation capabilities (Larone 1995). Candida species grow well at 20ºC
to 38ºC (Odds 1988a) and within the pH range from 2.5 to 7.5 (Odds 1988a), although a low
pH (Arendorf & Walker 1980, Parvinen & Larmas 1981) even below pH 2 (Odds & Abbott
1980) especially favors their proliferation. Candidal cells primarily multiply by budding.
Yeast cells are ovoid, 3 x 5 µm in size. C. albicans is a simple diploid eukaryote organism
lacking a sexual cycle. It grows in two forms, as a yeast (synonyms: blastospore;
blastoconidium) and as a hypha (synonym: mycelium). C. albicans, but also Candida
dubliniensis, produces germ tubes and chlamydospores. C. dubliniensis has been designated
as a separate yeast species, since it comprises a homogeneous genetic cluster,
phylogenetically distinct from the other Candida species (Sullivan et al. 1995). On the other
hand, because of the high DNA homology of C. albicans and C. stellatoidea (Donnelly et al.
1999), C. stellatoidea has been reclassified and moved to the species C. albicans as a sucrose-
negative variant of C. albicans (McCullough et al. 1999a).
Virulence factors
To colonize the oral cavity, C. albicans has to adhere to host surfaces (Cannon &
Chaffin 1999). C. albicans is a component of the adherent biofilm, as are bacteria, such as
streptococci and salivary glycoproteins on mucosal and acrylic surfaces (Holmes et al. 1995,
Cannon & Chaffin 1999). Adherence to such surfaces as human buccal epithelial cells
(Barrett-Bee et al. 1985, Gilfillan et al. 1998) and acrylic surfaces (McCourtie et al. 1986,
Nair & Samaranayake 1996) differs among yeast species. During recent years a vast amount
of work has been put to clarify the adherence mechanism, which is thought to be a key factor
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in the virulence. C. albicans possesses multiple adhesins and perhaps more than one adhesin
exists that recognizes a host ligand or cell. To date, most adhesins identified are mannoprotein
and in adherence, protein and/or carbohydrate portions have been implicated (Cannon &
Chaffin 1999). Yeast forms are considered responsible for colonizing epithelia, but the
hyphae are regarded as invasive structures of yeasts related to yeast infection (Cutler 1991).
Hyphal growth, initiated by germ tube formation (Barnes et al. 1983, Cutler 1991, Kretschmar
et al. 1999), increases adherence properties of yeasts (Samaranayake & MacFarlane 1982,
Odds 1994). Thigmotropism, contact sensing, may aid hyphae in penetrating tissues
(Sherwood et al. 1992) (Table 2).
C. albicans evades host defenses, for instance  by modulating phagocytic host defense
mechanisms or immune response by means of its surface properties including hydrophobicity
and by changing its surface structures with phenotypic switching (Diamond 1993). When
nutritionally stressed, C. albicans is able to adapt to different host microenvironments by
rapid switching of its phenotype (Soll 1992) or by secreting low molecular weight, iron-
chelating compounds known as siderophores (Sweet & Douglas 1991b, Howard 1999).
Additionally, C. albicans and other Candida species secrete hydrolases, including proteinases,
phospholipases, lipases, hexosaminidase, and phosphomonoesterase (Ruechel 1990, White et
al. 1993, Odds 1994, Wu & Samaranayake 1999, Ghannoum 2000) and produce acidic
metabolites including short-chain carboxylic acids (Ruechel 1990), and toxic substances, such
as carcinogenic nitrosamines (Krogh et al. 1987a). Enzymatic and metabolic activities damage
host cells and subsequently may interrupt the host cell functions. Although C. dubliniensis is a
closely related species to C. albicans, little information is available on its virulence.
Table 2. Putative virulence factors of C. albicans.
Virulence factora
Adherence
Persorption
Dimorphism
Germ tubes
Rapid switching of expressed phenotype
Thigmotropism
Surface hydrophobicity
Molecular mimicry
Interference with phagocytosis, immune defences and complement
Synergism with certain bacteria
Extracellular hydrolases (proteinases, lipases)
Anaphylatoxins
Killer toxins
Nitrosamines
Acidic metabolites
Growth rate
Undemanding nutrient requirement
a Modified from Ruechel (1990), Cutler (1991) and Odds (1994).
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Characterization of C. albicans isolates
Since C. albicans is a member of the normal oral flora (Arendorf & Walker 1979,
Odds 1988b) but is also able to cause oral and systemic candidosis, it is possible that the
pathogenic potential among C. albicans strains varies. Methods have therefore been
developed to distinguish among C. albicans strains. An optimal method for strain distinction
should be (1) capable of discriminating between epidemiologically unrelated strains, (2) be
reproducible, (3) not too laborious, (4) able to process a large number of strains, and (5)
comparatively inexpensive. Methods described in the literature for differentiating yeast strains
will be discussed below.
Phenotyping
Biotyping
Biotyping is based on differences in metabolic properties of yeast isolates. The
methods used for biotyping C. albicans isolates include a system of nine biochemical
assessments based on tests for acid and salt tolerance, proteinase production, resistance to 5-
fluorocytosine and safranine, and assimilation of urea, sorbose, citrate, and glycine (Odds &
Abbott 1980). Later, a test for boric acid resistance was added to the panel (Odds & Abbott
1983). A widely used commercial test, API ZYM, includes 19 hydrolytic enzyme reactions,
and a commercial API 20C system tests for assimilation of 19 different carbohydrates.
Additionally, a combination of these systems: API ZYM, API 20C, and resistance to boric
acid, has been used for biotyping C. albicans isolates (Williamson et al. 1987).
Except for the API ZYM system, the other biotyping methods differentiate well
among C. albicans isolates (Hunter 1991). The API ZYM system revealed only 4 to 9 C.
albicans biotypes from 126 to 213 clinical C. albicans isolates, whereas the other biotyping
methods distinguished 7 to 45 C. albicans biotypes from 23 to 130 subjects and isolates (Odds
& Abbott 1980, Williamson et al. 1986a, Krogh et al. 1987b, Williamson et al. 1987, Korting
et al. 1988, Rams & Slots 1991, Xu & Samaranayake 1995). Although the biotyping method
of Odds and Abbott (1980), which includes nine biochemical tests, allows in theory
differentiation of C. albicans into 512 biotypes, 160 C. albicans biotypes were found among
more than 700 isolates (Odds et al. 1983a, Odds et al. 1983b). This finding led to a suggestion
that all the theoretically possible 512 biotypes may not occur in nature (Odds et al. 1983a,
Odds et al. 1983b). Despite the broad variety of biotypes, one to two C. albicans biotypes
have commonly been predominant (21-75%) among clinical C. albicans isolates (Román &
Sicilia 1983, Williamson et al. 1986a, Williamson et al. 1986b, Krogh et al. 1987b,
Williamson et al. 1987, Korting et al. 1988, Rams & Slots 1991, Xu & Samaranayake 1995).
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The distribution of oral C. albicans biotypes differs between distant geographical
locales (Odds et al. 1983b, Xu & Samaranayake 1995). However, the same C. albicans
biotypes are found, and even the same C. albicans biotypes have been shown to predominate
in samples from diverse geographical locations (Williamson et al. 1986a, Williamson et al.
1987, Korting et al. 1988, Asakura et al. 1991, Rams & Slots 1991, Xu & Samaranayake
1995). No data have been published on oral C. albicans biotype diversity among Finnish
subjects other than that of Study II and of Waltimo (2000) on 37 C. albicans isolates from
apical periodontitis. Additionally, studies on C. albicans biotype diversity in diseased
periodontal pockets are limited (Rams & Slots 1991), although other oral and non-oral sites
have been studied more intensively (Odds et al. 1983b, Williamson et al. 1987, Xu &
Samaranayake 1995).
Within an individual, identical C. albicans biotypes have been concurrently isolated
from different anatomical sites (Odds & Abbott 1980, Odds et al. 1983a). C. albicans strains
of the same biotype usually persist within a subject (Odds & Abbott 1980, Odds et al. 1983a).
However, when the sampling interval was longer than 15 weeks, both oral and non-oral C.
albicans biotypes had a tendency to change (Odds et al. 1989).
No consistent association has been found in the literature between certain C. albicans
biotypes and oral or non-oral candidosis (Odds et al. 1983a, Odds et al. 1983b, Krogh et al.
1987b, Xu & Samaranayake 1995).
Serotyping
Serotyping of micro-organisms is based on detection of the reaction between the
antigen and the antibody raised against it. The methods commonly used for serotyping C.
albicans include Hasenclever tube agglutination (Hasenclever & Mitchell 1961a) and its
modification using a slide agglutination test (Drouhet et al. 1975, Stiller et al. 1982). These
tests are based on agglutination reactions of C. albicans cells and antisera raised in rabbits
against C. albicans serotype A or B strains (Hasenclever & Mitchell 1961a, Brawner & Cutler
1989). A commercial slide agglutination test uses monospecific antiserum raised in rabbits
immunized with extracted polysaccharide antigens of C. albicans serotype A cells (Iatron
factor 6) (Fukazawa et al. 1968, Shinoda et al. 1981). Additionally, C. albicans serotyping has
been carried out by indirect immunofluorescence assays using either serotype A-specific
rabbit antiserum (Auger et al. 1979) or monoclonal antibodies (H9) against extracted mannans
of C. albicans serotype A (Miyakawa et al. 1986), and recently, by flow cytometry based on
detection of immunocomplexes of the fluorescein-coupled antiserum of Hasenclever or Iatron
factor 6 and C. albicans cells (Mercure et al. 1996).
The serotyping techniques may give different results for the same C. albicans strains
(Brawner 1991). Slide agglutination tests using monoclonal antibody (H9) have matched
poorly with those using Iatron factor 6, probably because the immunoreagents recognize
19
different C. albicans antigens. Additionally, in the Hasenclever tube agglutination technique,
different lots of antisera (produced in different animals) resulted in different serotype results
(Brawner 1991). Flow cytometry has been suggested to be more reliable than slide
immunofluorescence for serotyping C. albicans isolates, since in flow cytometry the difficulty
of subjective interpretation of results is eliminated (Mercure et al. 1996).
Hasenclever and Mitchell first demonstrated two serotypes, A and B, among C.
albicans isolates (Hasenclever & Mitchell 1961a). Serotype differences are based on
differences in mannan branches in the cell wall of C. albicans (Kobayashi et al. 1992). The
antigenic differences result from variations in the bonding positions between mannose
residues and the number of residues in mannan side chains (Kobayashi et al. 1992). A third C.
albicans serotype, serotype C, was proposed in an early study (Müller & Kirchhoff 1969), but
it has not been widely accepted among researchers. Due to the current distinction between two
C. albicans serotypes, serotyping seems to be a rather ineffective tool for epidemiological
purposes.
The distribution of the two serotypes of C. albicans differs geographically. C. albicans
serotype A isolates are more frequently found in European countries (Stallybrass 1964,
Drouhet et al. 1975) than in North America (Hasenclever & Mitchell 1963, Auger et al. 1979,
Stiller et al. 1982). The distribution of C. albicans serotypes has been mainly studied in
samples originating from non-oral body sites (Hasenclever & Mitchell 1963, Stallybrass
1964, Drouhet et al. 1975, Auger et al. 1979, Stiller et al. 1982). In oral candidosis, C.
albicans serotype A is most commonly recovered (Martin & Lamb 1982, McMullan-Vogel et
al. 1999). On the other hand, researchers agree that the occurrence of C. albicans serotype B
isolates are associated with declining immune status (Brawner & Cutler 1989, Brawner et al.
1992). No relationship has, however, been found between C. albicans serotypes and virulence
characteristics (Hasenclever & Mitchell 1961b), except for the results presented in a study by
Kwon-Chung et al. (1988). They showed that sucrose-negative variants of C. albicans
serotype B isolates failed to produce infection in mice, whereas C. albicans serotype A caused
infections with 80% to 90% mortality. It has been suggested that C. albicans serotype A-
specific antigens are involved in the adherence of C. albicans serotype A isolates to human
buccal epithelial cells (Miyakawa et al. 1992). However, no difference has been found
between the two C. albicans serotypes as to their adherence to buccal epithelial cells (Imbert-
Bernard et al. 1994).
Within one individual, the distribution of C. albicans serotypes is similar at different
anatomical sites (Hasenclever & Mitchell 1963). Additionally, in repeated samplings, C.
albicans isolates are usually of the same serotype (Hasenclever & Mitchell 1963). However, it
is not known whether different C. albicans serotypes thrive in particular oral sites such as
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periodontal pockets and whether some bacteria enhance colonization of different C. albicans
serotypes in that ecological niche.
Genotyping
Recent advances in molecular biology have provided powerful tools for strain
distinction of C. albicans strains. The earliest molecular methods used for fingerprinting C.
albicans strains were karyotyping, restriction endonuclease analysis (REA), and restriction
fragment length polymorphism (RFLP). In karyotyping, very large chromosome-sized DNA
molecules can be separated with pulsed-field electrophoresis. REA determines variation in the
yeast genomes using various restriction endonucleases to detect differences in restriction
endonuclease cutting sites (in DNA sequences). In RFLP, fragments obtained by REA are
hybridized with DNA probes. REA generates a fingerprint pattern, with a higher number of
genomic restriction fragments than RFLP. However, the greater C. albicans genotype
discrimination ability of RFLP than of REA among clinical isolates (Diaz-Guerra et al. 1997)
is probably due to the less difficult interpretation of the RFLP fingerprints. In RFLP a wide
variety of probes, including a ribosomal DNA probe (Magee et al. 1987), a mitochondrial
DNA probe (Fox et al. 1989), a C. albicans-specific repetitive sequence DNA probe 27A
(Scherer & Stevens 1988, Fox et al. 1989), and a DNA midrepeat sequence probe Ca3 (Soll et
al. 1987, 1989, 1991, Schmid et al. 1990, 1992, 1993, Hellstein et al. 1993, Schröppel et al.
1994, Lockhart et al. 1995, 1996), have been used for the intraspecies discrimination of C.
albicans. RFLP analysis, especially with the widely used probe Ca3, has been reproducible
and suitable for differentiating C. albicans isolates. In arbitrarily primed polymerase chain
reaction (AP-PCR) analysis (Welsh & McClelland 1990) (synonym: randomly amplified
polymorphic DNA (RAPD) analysis) (Williams et al. 1990), the genomic DNA is used as a
template and amplified at a low annealing temperature, with use of a single short primer (9 to
10 bases) of an arbitrary sequence. AP-PCR is faster and technically less demanding to
perform than REA or RFLP, and it requires smaller amounts of target DNA. However, the
reproducibility of AP-PCR is dependent upon the careful standardization of the PCR
conditions, and the discriminatory power is dependent on the primer used and optimization of
the assay (Williams et al. 1990, Bostock et al. 1993, Dassanayake & Samaranayake 2000).
Although RFLP has been more discriminatory than AP-PCR (Pujol et al. 1997) and REA
(Diaz-Guerra et al. 1997) it is time-consuming and laborious and thus not well suitable for
routine epidemiological studies.
At the end of the 1980s, the molecular biological techniques REA and RFLP were
introduced for genotyping C. albicans. Later, in the beginning of the 1990s, AP-PCR was
introduced for fingerprinting C. albicans isolates. Prior studies, mainly using REA and RFLP,
indicate that the genetic diversity of C. albicans is high, and that certain C. albicans
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genotypes are geographically widely distributed (Stevens et al. 1990, McCullough et al.
1999b, Schmid et al. 1999) but also that geographical specificity exists among oral and non-
oral C. albicans isolates (Schmid et al. 1993, Clemons et al. 1997, McCullough et al. 1999b).
Within a subject, usually the same C. albicans genotype (Scherer & Stevens 1987, Fox
et al. 1989, Stevens et al. 1990, Whelan et al. 1990) but also different genotypes have been
recovered from different body sites (Scherer & Stevens 1988, Soll et al. 1989, Schmid et al.
1990, Xu et al. 1999). A study including four subjects reported a simultaneous recovery of
multiple oral C. albicans genotypes both from a HIV-negative and a HIV-positive subject
(Howell et al. 1996). The same C. albicans genotypes usually persist over time in oral and
non-oral body sites (Fox et al. 1989, Soll et al. 1989, Whelan et al. 1990).
Similar C. albicans genotypes appear in subjects with and without candidosis
(Powderly et al. 1992, Hellstein et al. 1993) and from oral candidosis of subjects with and
without HIV infection (Whelan et al. 1990, Howell et al. 1996). This is consistent with the
suggestion that candidosis is not caused by a unique or particularly virulent C. albicans strain
but more likely by a defect in host defense mechanisms (Whelan et al. 1990). To date, the
majority of studies have focused on studying C. albicans isolates from HIV-infected patients.
Of interest would be to see whether other immunocompromised patients with candidosis
harbor similar oral C. albicans genotypes as healthy subjects.
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AIMS OF THE STUDY
The aims of the present study were:
• to determine the timing and stability of yeast colonization, and the occurrence of various
  yeast species in the oral cavity of young children
• to clarify the role of the mother's oral cavity as a possible source of oral yeasts to her
  child
• to determine the identity and diversity of yeast species recovered from the oral cavity of
  systemically healthy adults
• to determine the clonal heterogeneity of subgingival C. albicans isolates within and
  between systemically healthy individuals from geographically distant locales
• to determine the relationship between the recovery of C. albicans and the simultaneous
  occurrence of periodontal pathogens
• to study whether differences exist in virulence attributes between C. dubliniensis and C.
  albicans and in the distribution of genotypes within each species between healthy
  individuals and those susceptible to yeast infections
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Table 3. Yeast isolates and subjects in Studies I-IV and methods used for culture and characterization of yeast isolates.
Study Yeast isolates/Subjectsa,b Origin of yeast isolates Methods
I Oral yeast isolates (N=104; 1-17 isolates/subject)
from 80 subjects
Mother-child pairs (N=40) from Finland Non-selective and selective agar media,
including SDA and TSBV
CHROMagar
AP-PCR (primer OPA-03)
II Oral yeast isolates
(N=362; 4-22 isolates/subject) from
Yeast-positive subjects from Finland (N=29) and the
United States (N=19)
SDA, TSBV
CHROMagar
- oral mucosa (N=52) The subjects exhibited Assimilation of carbohydrates
- subgingival sites (N=168) - non-periodontitis (N=15) AP-PCR (primer OPA-03)
- saliva (N=142) - adult periodontitis (N=32) REP-PCR (primer (GACA)4)
- early-onset periodontitis (N=1)
III Subgingival C. albicans isolates
(N=300; 5 isolates/subject)
C. albicans-positive routine dental clinic patients
from Finland (N=20), the United States (N=20), and
Turkey (N=20)
TSBV
CHROMagar
Serotyping
AP-PCR (primer OPE-03)
IV Oral yeast isolates
(N=93; 1-5 isolates/subject)
Yeast-positive subjects (N=40)
- C. albicans-positive routine dental clinic
SDA, TSBV
CHROMagar
C. albicans isolates (N=67) from
 - cheek mucosa (N=5)
   patients (N=9) and one child
- C. albicans-positive patients with APECEDc
AP-PCR (primer OPE-03)
Virulence characteristics:
 - saliva (N=36)
 - tongue (N=26)
  syndrome (N=21)
- C. dubliniensis-positive routine dental clinic
     - high-frequency phenotypic switching
     - phospholipase production
C. dubliniensis isolates (N=26) from   patients (N=9)d      - proteinase production
 - saliva (N=11)
 - subgingival sites (N=15)
     - siderophore production
a A total of 812 yeast isolates from 217 subjects were included in Studies I-IV. Several of the isolates were analyzed in more than one study.
b If not otherwise mentioned, the subjects showed no known disorder of the immune system or received no immunosuppressive medications.
c autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy
d
 Six patients from Finland and three from the United States.
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MATERIAL AND METHODS
SUBJECTS AND YEAST ISOLATES
Detailed descriptions of the material and methods are presented in the original
publications.
A total of 812 clinical strains from 217 subjects were included in the Studies I-IV
(Table 3). The 13 reference strains are shown in Table 4.
Table 4.  Reference strains in Studies I-IV.
Yeast species Reference strains
C. albicans NCPF 3179 (serotype A)
C. albicans CCUG 42415 (serotype B)
C. dubliniensis CD 36a
C. famata CCUG 662
C. glabrata NCPF 3309
C. guilliermondii CCUG 35875
C. intermedia CCUG 38422
C. krusei NCPF 3848
C. lusitaniae NCPF 3516
C. marxianus=C. kefyr CCUG 34328
C. parapsilosis NCPF 3872
C. tropicalis NCPF 3290
S. cerevisiae Baker's yeast
a A gift from D.L. Sullivan, Dublin, Ireland.
Study I was a prospective 22-month follow-up study, part of a comprehensive study
on factors affecting the carriage of respiratory pathogens and upper respiratory infections in
Finnish children from infancy up to two years of age. Unstimulated salivary samples of 40
children (21 females and 19 males) were collected with a sterile plastic pipette at the ages of
2, 6, 12, 18, and 24 months, and paraffin-stimulated salivary samples were collected from
their mothers (mean age 29 years, SD 5.6) at baseline. All salivary samples were cultured for
yeasts. Consecutive mother-child pairs participating at every sampling occasion were
included.
In Studies II to IV only yeast-positive subjects were included.
Study II used a cross-sectional study design. A total of 362 yeast isolates (4-22
isolates/subject) for the study originated in the oral mucosae (52 isolates), periodontal pockets
(168 isolates), and salivary samples (142 isolates) of 48 subjects (mean age 43 years, SD 17
years; 25 women and 23 men) with no known immunosuppressive conditions or medications.
Consecutive yeast-positive routine dental clinic patients were included. Twenty-nine of these
subjects were Finnish and 19 American. The periodontal status of these subjects included
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non-periodontitis (N=15), adult periodontitis (N=32), and early-onset periodontitis (N=1).
Except for two siblings, all subjects were unrelated to each other.
Study III was cross-sectional. The material consisted of 300 subgingival C. albicans
isolates (5 isolates/subject) from 60 C. albicans-positive consecutive routine dental clinic
patients from Finland (20 subjects; 11 women and 9 men; mean age 54.7 years, SD 10.8
years), the United States (20 subjects; 11 women and 7 men; ages unknown; 2 subjects of
unknown gender and age), and Turkey (20 subjects; 12 women and 8 men; mean age 31.8
years, SD 10.8 years). The subjects in Study III differed from those of Study II.
Study IV was cross-sectional. The material, 93 yeast isolates (1-5 isolates/subject)
from oral samples of 40 subjects, comprised 67 C. albicans isolates recovered from cheek
mucosa (5 isolates), saliva (36 isolates), and tongue (26 isolates) and 26 C. dubliniensis
isolates recovered from saliva (11 isolates) and subgingival sites (15 isolates). Nine
consecutive Finnish routine dental clinic patients and one Finnish child were chosen for the
study. Inclusion criteria included no known disorder of the immune system (defined as
healthy subjects) and C. albicans-positive oral samples. All 21 Finnish C. albicans-positive
patients with immuno-compromising autoimmune polyendocrinopathy-candidosis-ectodermal
dystrophy (APECED) syndrome were included. The C. dubliniensis isolates (N=26) were
from all nine routine dental clinic patients (6 Finnish subjects, 3 American subjects) with this
yeast species and with no known disorder of the immune system (defined as healthy).
CULTURE AND IDENTIFICATION OF YEAST SPECIES
The oral yeast samples obtained from the oral cavities of the study subjects were
inoculated on several non-selective and selective agar media including Sabouraud dextrose
agar with antibiotics (G-penicillin 20 U/ml, streptomycin 25 µg/ml) (Table 3). The samples
were cultured in the microbiology laboratories of the Institute of Dentistry, University of
Helsinki; School of Dentistry, University of Southern California; the National Public Health
Institute, Helsinki; and the Mycology Laboratory, Helsinki University Hospital.
 The identification of clinical isolates of C. albicans, C. dubliniensis, C. glabrata, C.
guilliermondii, Candida intermedia, C. krusei, C. lusitaniae, C. parapsilosis, and C. tropicalis
was carried out by established methods (Larone 1995, Sullivan et al. 1995) and commercial
kits (bioMèrieux Vitek, Lyon, France; CHROMagar, Paris, France; Difco Laboratories,
Detroit, MI, USA) presented in more detail in the original publications (Studies I-IV).
For all studies of this thesis, the single-colony yeast subcultures stored in 20% skim
milk (Difco Laboratories) at -70ºC were revived by culturing on Sabouraud dextrose agar
plates (Sabouraud dextrose, Oxoid, Hampshire, UK) or CHROMagar Candida Medium plates
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(CHROMagar, Paris, France). The yeast cultures were incubated in air at 37ºC for 2 days and
checked for purity.
PHENOTYPIC CHARACTERIZATION OF THE YEAST ISOLATES
Biotyping
Assimilation of carbohydrates was tested with the API 20C Aux kit (bioMèrieux
Vitek, Lyon, France). The reactions were assessed after 24, 48, and 72 hours of incubation at
30ºC according to the manufacturer's instructions. Each yeast isolate was tested one to three
times. In repeated testing, the assimilation results obtained with API 20C Aux kit were
reproducible. Biotyping is described more in detail in Study II.
Serotyping
C. albicans isolates were serotyped by using a slide agglutination test according to
manufacturer’s instructions (Candida Check, Iatron Laboratories, Inc., Tokyo, Japan). C.
albicans serotype A was identified based upon the presence of agglutination, and C. albicans
serotype B based upon absence of agglutination indicated by the commercial antiserum IF6
included in the kit. Isolates that autoagglutinated in saline after repeated testing were
characterized as non-serotypeable. Serotyping is described more in detail in Study III.
Virulence factors
The virulence factors were studied in Study IV.
High-frequency (10-2-10-1) phenotypic switching was determined by modifications of
the method of Jones et al. (1994). After incubation on Sabouraud dextrose agar plates, yeast
isolates were inoculated on agar plates of the medium of Lee et al. (1975) supplemented with
arginine and zinc (Anderson & Soll 1987). The ratio was calculated of the total number of
switched colonies to all colonies on the plate (Soll et al. 1987, Study IV). Each isolate was
tested once.
Phospholipase production of the yeast isolates was determined according to a
modification of the method of Price et al. (1982). After incubation on Sabouraud dextrose
agar plates, the yeast isolates were streaked on Sabouraud dextrose agar/Egg yolk plates
(Price et al. 1982), and the plates were incubated at 37°C for 48 hours. The phospholipase
activity of the isolates was interpreted as positive when a precipitation zone was visible
surrounding the growth. The phospholipase production of each isolate was tested twice.
Proteinase production of the yeast isolates was determined according to a modification
of the method of Ray and Payne (1990). After incubation on Sabouraud dextrose agar plates,
the yeast isolates were streaked on bovine serum albumin agar plates prepared according to
Staib (1965). After incubation, the plates were washed, stained, and destained. The proteinase
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activity of the isolates was interpreted as positive when a clarification zone was visible around
the growth. The proteinase production of each isolate was tested twice.
Siderophore production of the yeast isolates was determined according to a
modification of the methods of Schwyn and Neilands (1987) and Alexander and Zuberer
(1991). After incubation on Sabouraud dextrose agar plates, the yeast isolates were grown on
agar plates supplemented with iron (Sweet & Douglas 1991b). The siderophore production of
the isolates was interpreted as positive when a color change from light blue to pink was
visible around the growth, and the color of the growth changed from light cream to pink. The
siderophore production of each isolate was tested twice.
GENOTYPIC CHARACTERIZATION OF THE YEAST ISOLATES
DNA extraction
A rapid lysate method was developed for DNA extraction by modifying the method of
Bollet et al. (1991). Briefly, after incubation of yeast cells in Tris-EDTA (TE) buffer and
sodium dodecyl sulfate, the supernatant was discarded and the yeast pellet was heated in a
microwave oven and dissolved in TE buffer, and a 1:100 dilution of the cell lysate was used
as the DNA template in PCR amplification (Study II).
Genotyping
PCR genotyping of the yeast isolates was carried out with a repetitive sequence primer
(GACA)4 (Schönian et al. 1993), a random sequence primer OPA-03 (5'-AGTCAGCCAC-3',
Operon Technologies, Alameda, CA, USA), or a random sequence primer OPE-03 (5'-
CCAGATGCAC-3', Operon Technologies). The PCR amplifications were performed as
described in detail in the original publications (I-IV). Amplification products were analyzed
electrophoretically in 1% (OPA-03-PCR, (GACA)4-PCR) and 2% (OPE-03-PCR) agarose
gel, stained with ethidium bromide (0.5 µg/ml), visualized under ultraviolet light, and
photographed.
STATISTICAL ANALYSES
The statistical significance of differences in the frequency distributions of the
classified variables between the study groups was determined by Fisher’s exact test. Mann-
Whitney’s U-test served for comparing the means of the continuous variables with each other.
A P value <0.05 was considered statistically significant.
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RESULTS AND DISCUSSION
ORAL YEAST SPECIES IN YOUNG CHILDREN
Occurrence
Of the children, 43% (17/40) were yeast-positive at least once during the follow-up
period from 2 to 24 months of age. The recovery rate of salivary yeasts from children
remained nearly the same at each sampling occasion throughout the follow-up study (18% of
children yeast-positive at age 2 months, 13% at 6 months, 20% at 12 months, 20% at 18
months, and 13% at 24 months). Only a few other longitudinal studies on the occurrence of
oral yeasts in young children appear in the literature (Pedersen 1969, Russell & Lay 1973). In
contrast with the present findings, the recovery of oral Candida species from 140 infants
increased from seven days (14%) up to one month of age (82%) and then decreased from this
peak towards the age of two months (78%), six months (60%), and one year (50%) (Russell &
Lay 1973). Similarly, oral yeasts were recovered from 8% of 75 infants at the age of seven
days but from 41% at 5 to 12 months of age (Pedersen 1969). Due to the rather low number of
children included in the present study, the lower recovery rate of oral yeasts in the present
children up to the age of one year as compared with that in other studies is difficult to explain
except for chance. Because infants in the present study and in the prior studies (Pedersen
1969, Russell & Lay 1973) were randomly chosen, systemically healthy infants from Finland,
Denmark (Pedersen 1969) or England (Russell & Lay 1973), their differences in the health
status or geographical background do not clearly explain this difference in yeast recovery rate.
However, different sampling methods were used: salivary samples in the present study and
oral mucosal swab samples in the other two studies. Nor does inadequacy of the sampling
method seem to be the reason for the present low recovery rates. Saliva (30-40%) (Arendorf
& Walker 1980, Brambilla et al. 1992), imprint cultures (44-67%) using square foam pads
dipped in Sabouraud's broth to quantify yeasts in certain areas of the oral cavity (Arendorf &
Walker 1980, Samaranayake et al. 1986b), or rinse cultures (62-64%) (Samaranayake et al.
1986b, Berkowitz et al. 1994) have been shown to be superior to swab samples (17%) (Odds
1988b) for the recovery of oral yeasts from children and adults. Different culture methods, as
well may not explain this result. In the present study, oral yeasts were recovered from several
non-selective and selective agar media, including Sabouraud dextrose agar with antibiotics
(Larone 1995) and TSBV (our unpublished results) which support well the growth of yeasts,
whereas in the prior studies yeasts have been recovered from candida agar (Oxoid) after
incubation in Sabouraud's broth (Russell & Lay 1973) or from a solid growth medium for
yeasts which was not further specified (Pedersen 1969).
The recovery of oral yeasts from these children was associated with use of a pacifier
beyond age 12 months, eruption of the first teeth after six months of age, the mother cooling
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the child's food by blowing on it, and the mother cleaning the child's pacifier in her own
mouth. These results agree with those of prior studies in which recovery of yeasts was
associated with use of a pacifier or nursing bottle at night (Sio et al. 1987, Darwazeh & Al-
Bashir 1995, Ollila et al. 1997). As suggested by Sio et al. (1987) the habit of pacifier sucking
may disturb the ecosystem of the mouth, resulting in increased yeast recovery. Interestingly,
the occurrence of the yeasts in these children was not related to respiratory infections or use
of antibiotics. This disagrees with another Finnish study on 1-4-year-old children in whom the
occurrence of yeasts was associated with antibiotics (Ollila et al. 1997).
C. parapsilosis was recovered from 55% (18/33) and C. albicans from 36% (12/33) of
the yeast-positive salivary samples of children during the present 22-month follow-up study.
A significant difference (Ф2=0.2549, P=0.009) appeared between the detection rates of C.
parapsilosis and C. albicans beyond six months of age but not when all sampling occasions
were included. This finding was interesting, since to our knowledge, only a single earlier
study exists reporting a predominance of oral C. parapsilosis in young children (Contreras et
al. 1994). In that follow-up study on 124 Spanish children followed from 15 days to 16
months of age, C. parapsilosis was detected in 52% of all yeast-positive samples. Sampling
method seemed to have no effect on recovery rate of C. parapsilosis, since the organism
predominated both in salivary (Study I) and swab samples (Contreras et al. 1994). However,
in other studies on young children up to the age of two years―regardless of whether the study
subjects originated in Europe or the United States―C. albicans was the most frequently
detected oral yeast species (up to 59% of yeast-positive subjects), with C. parapsilosis the
next in frequency (up to 38% of yeast-positive subjects) (Pedersen 1969, Blaschke-
Hellmessen 1970, Kleinegger et al. 1996). This difference in the recovery rates of oral C.
parapsilosis (Contreras et al. 1994, Study I) and C. albicans (Pedersen 1969, Blaschke-
Hellmessen 1970, Kleinegger et al. 1996) cannot be explained by differences in age or health
status, since the children were of similar ages and with no diagnosed underlying systemic
disease.
Stability of colonization
Our results suggest that yeasts are transient colonizers of young children. Several
findings support this suggestion: No child among the 17 yeast-positive children was yeast-
positive at each of the five sampling occasions. Furthermore, yeasts were recovered at only
one sampling occasion from 35% (6/17) of the children. Yeasts were recovered at several
sampling occasions from 65% (11/17) of the children. Of these 11 children, six (55%)
exhibited different yeast species and five (45%) exhibited yeasts of only one single species
during the 22-month follow-up. The present results are in accordance with a previous
longitudinal study reporting inconsistent recovery of yeasts from children's oral cavities
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(Russell & Lay 1973). The authors suggested that the occurrence of Candida in oral samples
may have been underestimated, since swab samples were used instead of saliva and mouth
rinses. This may not be the case, because our own results obtained by use of salivary samples
corroborated.
Similar to C. albicans, C. parapsilosis also seemed to be a transient colonizer, and the
other yeast species were only infrequently found. C. albicans occurred in 55% (6/11) of yeast-
positive children who were yeast-positive at multiple sampling occasions (Table 2 from
original publication I). In 67% (4/6) of them, C. parapsilosis was detected later; 33% (2/6) of
the children with two solely C. albicans-positive samples were later yeast-negative. C.
parapsilosis occurred additionally in 45% (5/11) of children with multiple yeast-positive
sampling occasions. Of these children, 40% (2/5) harbored in addition to C. parapsilosis
another yeast species (C. guilliermondii, or C. lusitaniae and C. intermedia) at earlier
sampling occasions, and 60% (3/5) of the children with two or three solely C. parapsilosis-
positive samples were on earlier occasions and/or in between and/or at later sampling
occasions yeast-negative.
As previously suggested (Russell & Lay 1973), changes in the prevalence of oral
yeasts along with the age of the infant may be linked with simultaneous changes in the rest of
the developing oral microbial flora. To our knowledge, there are no studies in the literature on
the stability of oral yeast colonization in young children, at the individual level, except for one
single study on 21 infants followed from birth to the age of four weeks (Waggoner-Fountain
et al. 1996). In accordance with our results, none of those infants harbored yeasts at every one
of the four sampling occasions: yeasts occurred in 33% (7/21) of the infants, of whom 71%
(5/7) harbored yeasts at multiple (3/4) sampling occasions and 29% (2/7) at one single
occasion (Waggoner-Fountain et al. 1996). Multiple oral C. albicans-positive samples were
found in one infant in addition to multiple rectal C. albicans-positive samples. Rectal C.
albicans isolates were also recovered from two (40%) other infants. Multiple rectal C.
parapsilosis-positive samples were recovered from 40% (2/5) of the infants. The single non-
oral yeast-positive samples of two infants contained C. albicans and C. parapsilosis.
Yeast transmission from the mother
Saliva, in contrast to bioaerosols, is regarded as the most probable vehicle in the
person-to-person transmission of oral microbes (Asikainen & Chen 1999). Oral microbes are
likely transmitted via salivary contact from the mother to her child for example when the
mother cleans her child's pacifier in her own mouth or tastes the child's food with the child's
spoon. Therefore, salivary samples both from children and their mothers were studied to
determine whether the mother was a possible source of her child's oral yeasts.
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Fifty percent (20/40) of the mothers were yeast-positive, and 90% (18/20) of them
harbored exclusively C. albicans, 5% (1/20) both C. albicans and Saccharomyces cerevisiae,
and 5% (1/20) exclusively C. dubliniensis. Of these yeast-positive mothers, 35% (7/20) had a
child with at least one yeast-positive oral sample. Five of these seven mother-child pairs were
positive for C. albicans, and in three of these five pairs (60%), the AP-PCR profiles of the C.
albicans isolates were identical, suggesting transmission. Thus, probable transmission of
yeasts from the mother to her child via saliva was detected in 15% (3/20) of the yeast-positive
mothers and in 8% (3/40) of all the mother-child pairs.
In the present study, a single isolate only was analyzed. However, earlier studies have
suggested that one individual usually harbors only one C. albicans genotype (Fox et al. 1989,
Whelan et al. 1990). Thus, genotyping multiple C. albicans isolates from the present mother-
child pairs may not have changed the findings regarding identity and non-identity of the
strains within mother-child pairs. Information on the vertical transmission of oral yeasts
obtained by molecular biological techniques is limited. In agreement with the present results,
one study using REA for genotyping C. albicans isolates reported that oral or non-oral C.
albicans can be transmitted from mother to newborn (Waggoner-Fountain et al. 1996). They
showed that 24% (5/21) of the mother-child pairs were yeast-positive, of these, 60% (3/5)
harbored C. albicans, with the oral or rectal C. albicans strain being identical within each of
the three C. albicans-positive pairs. In another study, 60% (3/5) of C. albicans positive
mother-child pairs harbored an identical oral C. albicans isolate, as determined by AP-PCR
genotyping (Mehta et al. 1999).
Of our children, 23% (9/40) were yeast-positive despite the mother's oral samples
being yeast-negative. Although the oral route seems to be the source of yeasts from mother to
child (Pedersen 1969, Waggoner-Fountain et al. 1996, Mehta et al. 1999), C. albicans can be
also transmitted to the oral cavity of the child from other body sites which harbor C. albicans,
such as the mother's vagina during delivery (Kozinn et al. 1958). C. albicans is also recovered
from human skin and hands (Odds 1988b, Strausbaugh et al. 1994). Thus, in the present
study, despite C. albicans-negative oral samples, the role of the mother as the source of C.
albicans to her child cannot be fully ruled out.
Because oral yeast colonization in adults seems to be fairly stable (Samaranayake
1990a; own unpublished data), it was presumed that the baseline salivary sample of the
present mothers would define their yeast colonization status throughout the 22-month follow-
up period. Since only a baseline sample was collected from the mothers, in 57% (4/7) of the
yeast-positive mother-child pairs the yeast isolates were not recovered at the same sampling
occasion. Four of the seven children from the yeast-positive mother-child pairs were yeast-
negative at baseline but later positive. Although the baseline sample of the child was yeast-
negative, yeasts may have existed but below the present detection level.
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C. parapsilosis was recovered from none of the mothers although it was recovered
from 33% (13/40) of the children. The oral cavity of the mother thus did not seem to be the
source of C. parapsilosis to her child. In contrast to C. albicans, the source of C. parapsilosis
for the child is probably not the vaginal flora of the mother during delivery (Waggoner-
Fountain et al. 1996) because C. parapsilosis is only a minor finding in the vaginal flora,
whereas the most common species is C. albicans (Sonck 1978, Sautter & Brown 1980,
Goldacre et al. 1981). However, C. parapsilosis can be found on human skin surfaces
(Weems 1992) and may thus, for instance, be transmitted from breast skin to the child
(Weems 1992, Sanchez et al. 1993, Strausbaugh et al. 1994). All the children in the present
study were breastfed. On the other hand, C. parapsilosis may have also been transmitted from
the hands of people caring for the infant (Weems 1992, Sanchez et al. 1993, Strausbaugh et al.
1994). C. parapsilosis is the most frequently isolated Candida species recovered from the
hands of nurses (50%) and other hospital personnel (67%) (Strausbaugh et al. 1994), and C.
parapsilosis can thus probably be transmitted to the patients via hands of hospital personnel.
C. parapsilosis has been suggested to be transmitted between neonatal intensive care unit
patients via the hands of nurses (Saxen et al. 1995). Sanchez et al. (1993) indicated that
among patients who were C. parapsilosis-negative before admission to the hospital, the
organism was later found in samples taken from the oropharynx, stool, vagina or wounds. The
C. parapsilosis strains from four of five patients were of the same genotype as the strains
cultured from the hands of several staff members  (Sanchez et al. 1993). Three genotypes of
C. parapsilosis were found, of which one was recovered from 80% (4/5) of patients and 75%
(3/4) of staff members and from environmental surfaces tested.
IDENTIFICATION, OCCURRENCE AND CHARACTERISTICS OF C.
DUBLINIENSIS
Isolates included in Study II showed an AP-PCR and a REP-PCR -profile typical for
C. albicans except for four isolates, which despite biochemical similarity to C. albicans,
produced an "atypical" PCR-profile. This atypical PCR-profile was similar to the profile of
the type strain of C. dubliniensis which has recently been separated from C. albicans as a
novel Candida species (Sullivan et al. 1995, Coleman et al. 1998). Thus, these four isolates,
presumptively identified as C. albicans (Study II), were later during this study (Study IV)
designated as C. dubliniensis. C. dubliniensis was originally reported to produce abundant
chlamydospores which are frequently arranged in triplets or contiguous pairs, in contrast to
the single chlamydospores of C. albicans (Sullivan et al. 1995). However, the present findings
(Study I, II, IV) agree with the results of Kirkpatrick et al. (1998) and Schoofs et al. (1997)
who observed no difference in the number of chlamydospores, or their formations, between C.
albicans and C. dubliniensis isolates.
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In some studies, C. dubliniensis has been differentiated on CHROMagar Candida
Medium by its dark green colonies as compared to the lighter green colonies of C. albicans
(Coleman et al. 1997a, Sullivan et al. 1997). Our results are in agreement with the results of
other researchers (Schoofs et al. 1997, Tintelnot et al. 2000) who could not differentiate C.
albicans and C. dubliniensis isolates by color of colonies. According to these observations,
both species grew as an equal shade of green-colored colonies on CHROMagar Candida
Medium plates. The present C. dubliniensis isolates did not assimilate xylose (Study II); such
non-assimilation is regarded as a typical property of C. dubliniensis (Sullivan et al. 1995,
Kirkpatrick et al. 1998, Gales et al. 1999, Pincus et al. 1999). Originally, Sullivan et al. (1995)
reported that C. dubliniensis does not grow at 42ºC when incubated on potato dextrose agar or
yeast peptone dextrose broth. All the present C. dubliniensis isolates were able to grow at
42ºC on Sabouraud dextrose agar (Study II). It was recently reported that some strains of C.
dubliniensis were, however, able to grow at 42ºC but not at 45ºC on Sabouraud dextrose agar
or on Emmons' modified Sabouraud glucose agar (Kirkpatrick et al. 1998, Pinjon et al. 1998,
Jabra-Rizk et al. 1999), but our C. dubliniensis isolates were not tested for growth at 45°C.
Genotypic methods have recently provided rapid and reliable tools for the species
differentiation between C. albicans and C. dubliniensis (Sullivan et al. 1995, Coleman et al.
1997a, Pujol et al. 1997, Sullivan & Coleman 1998). In the present studies both the random
sequence primers and the repetitive sequence primer easily differentiated C. dubliniensis from
C. albicans (Study I, II, IV).
The majority of C. dubliniensis isolates reported in the literature have been recovered
from the oral cavity, suggesting that this species may be particularly adapted to oral
colonization (Sullivan et al. 1995, Coleman et al. 1997b, Gilfillan et al. 1998). There are,
however, studies indicating that it can also be isolated from blood, feces, sputum, and the
vaginal flora (Odds et al. 1998, Pfaller et al. 1998, Pinjon et al. 1998). In early studies, C.
dubliniensis was mainly found in HIV-infected subjects (Sullivan & Coleman 1998).
However, the present C. dubliniensis isolates were recovered from saliva and subgingival
sites of subjects with no known disorder of the immune system. Recently, other investigators
have also reported recovery of C. dubliniensis from subjects not described as HIV-infected
(Moran et al. 1997, Odds et al. 1998).
Since data on C. dubliniensis are still limited, the purpose of the present study (Study
IV) was to screen for differences between C. dubliniensis and C. albicans as regards a number
of virulence factors in addition to genotype differences, with tests being chosen that produce
results that could be interpreted simply as positive or negative. Information from these studies
was intended to assist in focusing future studies on certain virulence characteristics.
 The C. dubliniensis isolates studied here showed phenotypic switching more
frequently (70%) than did the C. albicans isolates (22%), a finding that suggests that in this
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respect C. dubliniensis isolates exhibit higher virulence than C. albicans isolates. The ability
of a microbe to adapt to environmental changes by switching its phenotype is considered an
important virulence factor (Soll 1992). These results are interesting since no earlier data seem
to exist on switching of C. dubliniensis. However, contrary to the general assumption that C.
dubliniensis may be more virulent than C. albicans, one earlier study suggested in a mouse
model lower virulence for C. dubliniensis (Gilfillan et al. 1998). In a similar way, our findings
on production of phospholipase and proteinase, suggest that the C. dubliniensis isolates
exhibit lower virulence than the C. albicans isolates. Our C. dubliniensis isolates did not
produce phospholipase, and thus phospholipase production was less frequent among the C.
dubliniensis isolates than among the C. albicans (56%) isolates. Only one study was found in
which the quantity of phospholipase production seemed to be similar among oral C.
dubliniensis and C. albicans isolates (Bennett et al. 1998). Our study is probably the first to
indicate that the C. dubliniensis isolates produced proteinase less often (10%) than did the C.
albicans isolates (50%) but no significant difference appeared in the production of
siderophores between the C. dubliniensis (100%) and C. albicans (81%) isolates. As the
number of tested isolates was limited, further studies using methods that allow more detailed
analyses are needed to clarify whether switching ability is a prominent virulence factor of C.
dubliniensis.
INTERINDIVIDUAL HETEROGENEITY OF ORAL YEASTS
Geographical differences
Yeast species
In Study II, 10 random sequence PCR primers were tested for their ability to
discriminate within and between different yeast species. The results indicated that AP-PCR
amplification with the random sequence primer OPA-03, or PCR with a repetitive sequence
primer (GACA)4 generated distinct amplicon patterns for the yeast species C. albicans, C.
dubliniensis, C. famata, C. glabrata, C. guilliermondii, C. intermedia, C. krusei, C. lusitaniae,
C. kefyr, C. parapsilosis, C. tropicalis, and S. cerevisiae.
Detection rates for oral C. albicans and C. dubliniensis were similar among yeast-
positive subjects from Finland and the United States (Study II). C. albicans isolates were
recovered from 93% (27/29) of Finnish subjects and 89% (17/19) of American subjects. C.
dubliniensis was recovered from 7% (2/29) of Finnish subjects and 11% (2/19) of American
subjects. In addition to oral C. albicans, C. glabrata, C. krusei, or S. cerevisiae were found
concurrently in three Finnish subjects. The American subjects, from whom five isolates per
subject were analyzed, did not harbor other yeast species concurrently with C. albicans. Our
finding that C. dubliniensis was detected from both Finland and the United States supports the
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assumption that C. dubliniensis is distributed worldwide (Sullivan et al. 1997, Jabra-Rizk et
al. 1999, McCullough et al. 1999b, Polacheck et al. 2000). Moreover, the present results on
the infrequent recovery of yeast species other than C. albicans from the oral cavity are in
concordance with prior studies (Arendorf & Walker 1980, Brambilla et al. 1992).
C. albicans biotypes and serotypes
The C. albicans isolates from 44 Finnish and American subjects (Study II) were
divided into six biotypes based on carbohydrate assimilation profiles of the API 20C Aux kit.
C. albicans populations seem to share similarities worldwide as regards biotype distribution.
Among the Finnish and American isolates, C. albicans biotype 2576174 predominated (79%).
This same biotype is common (57-88%) in previous studies (Williamson et al. 1986a, Korting
et al. 1988, Asakura et al. 1991, Rams & Slots 1991) from diverse geographical locations,
including Germany, Great Britain, Japan, and the United States. Besides the oral cavity,
isolates of this biotype have also been recovered from other body sites (Williamson et al.
1986a, Korting et al. 1988, Asakura et al. 1991, Rams & Slots 1991). Furthermore, two other
Finnish biotypes of C. albicans (2566174 and 2546074), comprising 4% of the present
isolates, were found in 9% of the American isolates studied by Rams & Slots (1991). The
remaining four yeast isolates, all of which turned out to be C. dubliniensis, were of three
additional biotypes solely found among C. dubliniensis isolates. It appeared that the API 20C
Aux kit is unable to identify some C. albicans isolates, as also noticed by Aly et al. (1995).
One Finnish C. albicans and one C. dubliniensis isolate remained unidentified by this kit.
C. albicans serotype A was detected significantly more frequently in subjects from
Finland (80%) and Turkey (100%) than from the United States (45%) (Study III). Although
no other studies were found on the distribution of C. albicans serotypes among isolates from
Finland or Turkey, the present finding does generally agree with studies in which the
occurrence of serotype A has varied from 75% to 94% of isolates recovered from European
countries (Stallybrass 1964, Drouhet et al. 1975) and from 51% to 68% of isolates recovered
from the United States (Hasenclever & Mitchell 1963, Stiller et al. 1982).
C. albicans genotypes
Since the intraspecies distinction of C. albicans in Studies I and II remained rather
poor with the primers OPA-03 and (GACA)4 another random sequence primer, OPE-03, was
tested which improved the differentiation among C. albicans strains and was thus used in
Studies III and IV. It could be seen that one of the 25 C. albicans genotypes distinguishable
among the present 300 isolates from 60 C. albicans-positive routine dental clinic patients
occurred at a particularly high frequency (50% of yeast-positive subjects) in subjects from
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Turkey, whereas another genotype was rather common in subjects from the United States
(35% of yeast-positive subjects) (Study III). No previous studies concerned subgingival C.
albicans genotypes. C. albicans strains shared only one single genotype in all three countries
and another genotype in both Finland and Turkey. The other 23 C. albicans genotypes were
single findings.
Differences in geographic distribution of C. albicans genotypes have previously been
suggested (Schmid et al. 1993, Pfaller et al. 1998, McCullough et al. 1999b). For instance, C.
albicans isolates from various geographical locations, including Africa, Asia, Australia,
Europe, and South America, showed a similar genotype distribution, one distinct from that
found in the United States and Israel (McCullough et al. 1999b). Somewhat unexpectedly, 12
C. albicans genotypes were distinguished in the present 20 Finnish subjects, but seven from
the 20 American and nine from the 20 Turkish subjects. The ethnically homogeneous
population of Finland was originally anticipated to harbor relatively few C. albicans
genotypes, whereas the heterogeneous population of the United States was expected to harbor
several. However, based on our results the C. albicans population seems to be heterogeneous
in each country, not directly dependent upon ethnic factors but rather showing clustering of
certain clones in differing geographic areas.
C. albicans isolates in relation to systemic health
Genotypes and virulence factors
AP-PCR, with OPE-03 as a primer, distinguished 15 C. albicans genotypes from 21
immunocompromised subjects with APECED and six genotypes from the 10 healthy subjects
(Study IV). No significant difference appeared between patients with APECED and healthy
subjects in number of genotypes or in occurrence of virulence factors of C. albicans isolates
(Study IV).
Our findings were in agreement with those of one study in which the diversity of oral
C. albicans genotypes between HIV-infected and systemically healthy subjects was similar
(Xu et al. 1999). However, in an even earlier study, the diversity of oral C. albicans genotypes
was lower among 11 immunocompromised subjects (AIDS) than in 16 systemically healthy
subjects (Schmid et al. 1992). The authors suggested that the original commensal C. albicans
strains had been replaced with a new one in AIDS patients, because 45% (5/11) of the
unrelated patients with AIDS harbored genetically similar strains. The discrepancies between
these studies may result from chance, due to the limited number of subjects or to differences
between study populations. The present subjects were immunocompromised patients with
APECED and chronic oral candidosis; the others were patients with AIDS (Schmid et al.
1992). Genotyping methods also differed between studies, AP-PCR and RFLP, respectively.
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Though we conclude, that further studies with a higher number of subjects are still needed to
clarify, whether the diversity of C. albicans genotypes is decreased in immunocompromised
subjects or is related to immune status.
The same C. albicans genotypes were recovered from our systemically healthy
subjects as from the immunocompromised patients with APECED, a result in agreement with
earlier findings in which the distribution of the C. albicans genotypes did not differ among
immunocompromised patients with AIDS and healthy subjects (Whelan et al. 1990).
Candidosis associated with AIDS is probably not caused by an especially virulent strain but is
likely a consequence of a defect in the host's defense mechanisms (Whelan et al. 1990). This
assumption was supported by the finding that no particular C. albicans genotype is associated
with HIV-infection. Oral C. albicans isolates were suggested to have a common clonal origin
in patients with or without HIV infection (Boerlin et al. 1996).
No significant differences were found in high-frequency phenotypic switching (28%
vs. 10% of isolates), phospholipase production (52% vs. 60%), proteinase production (48%
vs. 60%), or siderophore production (86% vs. 70%) for oral C. albicans isolates between our
immunocompromised patients with APECED and candidosis and our systemically healthy
subjects (Study IV). These results agree with the findings of Hellstein et al. (1993) who
showed phenotypic switching among 34% of C. albicans isolates obtained from oral
candidosis and among 15% of C. albicans isolates from healthy subjects. Contrary to the
present results, in the study of Wu et al. (1996) all oral C. albicans isolates from patients with
HIV infection exhibited proteolytic ability, but only 56% of the isolates from HIV-negative
subjects. The discrepancies in presented results do not seem to be methodological, since in
both studies proteinase production was tested on similar bovine serum albumin agar plates.
There are only a few studies reporting on siderophore production of C. albicans (Holzberg &
Artis 1983, Sweet & Douglas 1991b), and these usually present a limited number of C.
albicans isolates, with the main focus on determining siderophore types. Of the present 31 C.
albicans isolates, 81% produced siderophores, which largely agrees with findings that all 12
C. albicans strains from subjects with various pathologies and in asymptomatic patients, in
regard to candidosis, produced siderophores (Sweet & Douglas 1991a).
INTRAINDIVIDUAL HETEROGENEITY OF ORAL YEASTS
Yeast species
Of subjects with no known immunosuppression, 85% (41/48) harbored only C.
albicans isolates and 8% (4/48) only C. dubliniensis isolates (Study II). In addition to oral C.
albicans, also C. glabrata, C. krusei, or S. cerevisiae occurred in 6% (3/48). The novel
chromogenic medium (CHROMagar Candida Medium) used in the present Studies I-IV for
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presumptive identification of Candida species facilitates recovery of different yeast species
from mixed cultures. In contrast to studies concentrating on usually only one yeast isolate per
subject, we studied 4 to 22 yeast isolates per subject. Our results are in concordance with
those of studies reporting yeast species other than C. albicans have seldom been recovered
from systemically healthy subjects (Arendorf & Walker 1980, Brambilla et al. 1992). Unlike
our findings, oral C. dubliniensis has been recovered concurrently with other yeast species
(Coleman et al. 1997b, Schoofs et al. 1997). Such a discrepancy may be explained by
difference in subjects, since our C. dubliniensis isolates were from subjects with no known
disorder of the immune system, but the prior isolates from HIV-positive subjects and AIDS
patients (Coleman et al. 1997b, Schoofs et al. 1997). Immunosuppression may permit
colonization of several coexisting yeast species in the oral cavity.
C. albicans serotypes and genotypes
All five subgingival C. albicans isolates per subject from 60 routine dental clinic
patients were, within each individual, of the same serotype or non-serotypeable, except for
two American subjects who had both serotype B and non-serotypeable isolates (Study III). A
literature search revealed no report of two concurrent oral C. albicans serotypes per
individual; on different sampling occasions one single individual may harbor oral or non-oral
isolates of one single C. albicans serotype (Hasenclever & Mitchell 1963).
With the primer OPE-03, the discriminative power of the AP-PCR method was
relatively high, since it distinguished altogether 33 C. albicans genotypes among clinical
isolates recovered from 91 subjects and one additional genotype in a reference strain (Studies
III and IV). Pujol et al. (1997) found the same primer to generate 17 C. albicans genotypes
among isolates from 22 subjects, again indicating the favorable discriminative capability of
the primer OPE-03. A single C. albicans genotype was found in each healthy subject from
Finland, the United States, and Turkey among the multiple (N=5) C. albicans isolates per
subject (Study III, IV), except for two subjects from Turkey who each harbored two
genotypes, of C. albicans serotype A (Study III). This agrees with prior studies including
several isolates per subject and indicates that one individual usually harbors a single oral C.
albicans genotype (Hellstein et al. 1993, Lockhart et al. 1995, Kleinegger et al. 1996). In
these studies the subjects were healthy (no evidence of candidosis or HIV-infection).
However, in immunocompromised subjects, findings as to the intraindividual diversity of oral
yeasts have been contradictory. A single genotype (Miyasaki et al. 1992, Boerlin et al. 1996)
or simultaneously occurring multiple genotypes (Anthony et al. 1995, Redding et al. 1997) of
C. albicans have been recovered among strains from single subjects.
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C. dubliniensis genotypes
The AP-PCR technique with the primer OPE-03 distinguished two genotypes among
the 27 oral C. dubliniensis isolates originating from nine systemically healthy subjects (Study
IV). Except for one subject with two concurrent C. dubliniensis genotypes, each subject
(N=8) harbored only one. The recovery of only two genotypes may result from the limited
number of subjects and isolates tested but also from the fact that the primer was originally
optimized for C. albicans. It is thus too early to draw conclusions about intraspecies diversity
of C. dubliniensis until further testing is performed with other AP-PCR primers, or other
genotyping methods. Studies have focused mainly on detecting C. dubliniensis in clinical
samples and differentiating it from C. albicans. Only recently, the intraspecies diversity of C.
dubliniensis has been investigated (Diaz-Guerra et al. 1999, Joly et al. 1999). Fifty-seven C.
dubliniensis isolates, each from a different subject, exhibited distinct RFLP hybridization
patterns (N=53) which were further separated into two distinct genetic clusters (Joly et al.
1999). To date, no studies in addition to the present one have focused on the intraindividual
diversity of C. dubliniensis genotypes.
SUBGINGIVAL C. ALBICANS AND OCCURRENCE OF PERIODONTAL
PATHOGENS
A few, albeit geographically inconsistent, associations were evident in the
comprehensive analyses of the data between detection of C. albicans and of periodontal
pathogens from the same samples (Study III). Results on total bacterial counts, detection, and
proportions of various periodontal pathogens in relation to the presence or absence of C.
albicans are discussed below.
First, mean subgingival bacterial counts based on colony-forming units (CFU) were
similar in C. albicans-positive  (1.5x108 CFU, SD 2.7x108) and C. albicans-negative
(1.9x108 CFU, SD 3.7x108) subjects.
 Second, when the number of periodontopathogenic species: A.
actinomycetemcomitans, P. gingivalis, P. intermedia sensu lato, B. forsythus, P. micros, and
C. rectus in subgingival samples was compared to the simultaneous occurrence of C.
albicans, the number of detected species was significantly lower among C. albicans-positive
Finnish and American subjects than among -negative subjects (10 vs. 15, Ф2=0.070, P=0.031
and 14 vs. 27, Ф2=0.590, P=0.035, respectively). Interestingly, the recovery of significantly
(Ф2=0.1837, P=0.013) fewer species of periodontal pathogens per sample also concerned
samples with C. albicans serotype A isolates from Finland and the United States.
Nevertheless, these results suggest that C. albicans, and especially serotype A isolates, may
thrive in healthy periodontal sites or along with only a few species of periodontal pathogens.
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Third, among the selected periodontal species, P. gingivalis was recovered
significantly (Ф2=0.1064, P=0.008) less frequently from C. albicans-positive (29%, 5/17)
than -negative (67%, 34/51) subjects in Finland. This finding makes sense because of the
differing environmental preferences of P. gingivalis and C. albicans: in diseased subgingival
sites, oxygen pressure is low, host-derived proteins are readily available, and carbohydrate
nutrients are limited, all of which favors the obligately anaerobic, proteolytic, asaccharolytic
P. gingivalis but not the aerobic, fermentative C. albicans. Additionally, the mean proportion
of A. actinomycetemcomitans among the flora was significantly (Z=-2.271, P=0.023) higher
in Finland among C. albicans-positive (mean 0.9, SD 0.9) than -negative (mean 0.1, SD 0.1)
subjects. This may be expected, since a similar type of subgingival ecology may favor the
growth of both organisms, namely the facultatively anaerobic, saccharolytic A.
actinomycetemcomitans and C. albicans. Coaggregation between yeasts and bacteria may be
an important factor in the microbial colonization and progression of infections in the oral
cavity. Although no studies on coaggregation between oral C. albicans and periodontal
pathogens were found, it is known that C. albicans binds to several dental plaque bacteria
including viridans streptococci (Jenkinson et al. 1990, Holmes et al. 1996), Fusobacterium
(Grimaudo & Nesbitt 1997), and Actinomyces species (Grimaudo et al. 1996). The present
study is, to the best of our knowledge, the first to address the question of the coexistence of C.
albicans and periodontal pathogens in subgingival sites. These results have to be considered
preliminary findings, but they encourage further studies to investigate environmental factors
favorable for subgingival colonization and persistence of C. albicans. In the future, in vitro
studies should show whether certain periodontal bacteria inhibit or favor the growth of yeasts
or vice versa.
41
SUMMARY AND CONCLUSIONS
The present study used phenotypic and genotypic methods to determine the stability of
oral yeast colonization in young children and to characterize oral yeasts recovered from
children and adults. Additionally, an attempt was made to determine the timing of yeast
colonization in the oral cavity of infants and to clarify the role of the mother's oral cavity as a
possible source of oral yeast infection for the child. The clonal heterogeneity of oral C.
albicans isolates was determined between and within subjects from geographically distant
locales: Finland, the United States, and Turkey. The simultaneous occurrence of C. albicans
with the periodontal pathogens A. actinomycetemcomitans, P. gingivalis, P. intermedia sensu
lato, B. forsythus, P. micros, and C. rectus was additionally studied. Finally, certain virulence
attributes were compared between C. dubliniensis and C. albicans isolates and between C.
albicans isolates from subjects with or without a compromised immune response.
All clinical yeast isolates (812 isolates from 217 subjects) included were subcultured
on CHROMagar Candida Medium plates for tentative identification. Phenotypic
characterization of the isolates was carried out with biotyping and serotyping. PCR was
chosen as the technique for genotypic characterization of the yeast isolates because of its
relative rapidity and easiness to perform, which allows characterization of a large number of
isolates. The random sequence primer OPE-03 improved the intraspecies differentiation of C.
albicans compared to the primers (a random sequence primer OPA-03 and a repetitive
sequence primer (GACA)4) used in the first two studies of the thesis, and so was subsequently
used in the two later studies. With the primer OPE-03, a total of 33 genotypes were
distinguished among 367 clinical C. albicans isolates from 91 subjects and two genotypes
among 26 clinical C. dubliniensis isolates from nine subjects.
Yeasts were found to be transient colonizers in the developing oral flora of young
children, as assessed from salivary samples obtained at ages 2, 6, 12, 18, and 24 months. No
child was yeast-positive at each of the five sampling occasions. Of the yeast-positive children,
35% harbored yeasts at one sampling occasion, 41% at two sampling occasions, 18% at three,
and 6% at four occasions. Yeasts were recovered on at least one occasion from 43% of
children by the age of two years. However, only 28% of children were yeast-positive at
multiple sampling occasions. The same yeast species was rarely (18%) detected in successive
follow-up samples. C. parapsilosis was the most common species (76%) followed by C.
albicans (24%) in samples obtained at ages over 6 months. Of the mothers, 50% harbored
salivary yeasts when tested at baseline, and 95% of the yeast-positive mothers had C.
albicans. Of these C. albicans-positive mothers, 26% had a C. albicans-positive child, but no
child with C. parapsilosis had a C. parapsilosis-positive mother with oral sample. The AP-
PCR genotypes of the C. albicans isolates varied between mother-child pairs, but were
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identical within 60% of the pairs, suggesting transmission of oral C. albicans between mother
and child.
C. albicans was the oral yeast species most frequently recovered from adults (93%).
Other yeast species alone (7% of subjects) or together with C. albicans (6%) were rare
findings. Only a single oral C. albicans genotype was usually recovered within a subject (97%
of subjects).
Geographical differences were evident in the distribution of C. albicans serotypes and
genotypes. C. albicans serotype A was recovered significantly more frequently from the
Finnish and Turkish than the American subjects. Additionally, one C. albicans genotype
occurred with particularly high frequency in subjects from Turkey and another genotype in
subjects from the United States, but none in subjects from Finland.
The present study seems to be the first to study serotypes and genotypes of
subgingival C. albicans isolates. Subgingival ecology did not seem to favor any particular
genotypes. Despite comprehensive analyses, only a few associations were found between the
recovery of C. albicans and of certain periodontal pathogens, and these associations were,
geographically inconsistent.
The C. dubliniensis isolates exhibited high-frequency phenotypic switching
significantly more frequently, but phospholipase and proteinase production less frequently
than for the C. albicans isolates. However, no significant difference was found in the
expression of these virulence factors or in the distribution of genotypes of C. albicans isolates
between the subjects with APECED, whose immune system is compromised, and
systemically healthy subjects.
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The main conclusions are that:
• In the developing oral flora of young children yeasts are transient colonizers, C. parapsilosis
  and C. albicans being the most frequently occurring species.
• A child's oral C. albicans is partly explained by transmission from the mother, whereas the
  source of C. parapsilosis remains to be settled.
• A subject usually harbors only a single genotype and serotype of oral C. albicans, which is
  the most common oral yeast species in healthy adults.
• C. albicans, of which different serotypes and genotypes cluster in geographically distant
  sites, may be coincidentally present in periodontal pockets.
• Differences appear in the virulence determinants between C. dubliniensis and C. albicans
   isolates but not in the virulence determinants or the genotype distribution between C.
   albicans isolates recovered from healthy individuals or those susceptible to yeast
   infections.
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